NEXTBio Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States
Industries Focus
- Healthcare
- Life Sciences
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Regenerative Medicine
- Oncology
- Infectious Diseases
- Immunology
- Genomics
- Rare Diseases
- Neuroscience
- Biotech Research
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2024
NEXTBio Capital is a venture capital firm specializing in early-stage investments within the life sciences sector. The firm focuses on identifying and supporting innovative companies that are developing breakthrough medical technologies and therapies. By leveraging advanced data analytics and machine learning, NEXTBio Capital aims to accelerate the growth of its portfolio companies and bring transformative solutions to the healthcare market.
The firm's investment strategy encompasses a wide range of life sciences industries, including biotechnology, pharmaceuticals, medical devices, diagnostics, and various therapeutic areas such as oncology, immunology, and rare diseases. NEXTBio Capital typically invests in companies at various stages of development, from early-stage startups to growth-stage enterprises, providing capital and strategic guidance to help them achieve their milestones and scale operations.
With a commitment to fostering innovation and improving patient outcomes, NEXTBio Capital seeks to partner with visionary entrepreneurs and research teams. The firm emphasizes a collaborative approach, offering not only financial support but also access to a network of industry experts and resources to drive success. Through its investments, NEXTBio Capital contributes to the advancement of medical science and the development of therapies that address unmet medical needs.
Requirements
- Innovative medical technologies
- Strong management teams
- Scalable business models
- Clear regulatory pathways
- Potential for significant market impact
Contact
[Official Website Hidden]
[HQ Location Hidden]
Portfolio Companies
- Shattuck Labs
- Vor Biopharma
- ORIC Pharmaceuticals
- Evommune
Claim this Investor
Are you an official representative of NEXTBio Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim